Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Viral Immunology|March 24, 2006
Improvement of neutralizing activity of human scFv antibodies against hepatitis B virus binding using CDR3 V(H) mutant librarySae-Gwang Park, Young-Joo Jung, Young-Yi Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 20, 2015
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysisJia-Horng Kao, Donald M Jensen, Michael P Manns, et al.
Journal of Hepatology|December 12, 2018
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trialJoong-Won Park, Yoon Jun Kim, Do Young Kim, et al.
Journal of Medical Virology|November 26, 2010
Serum HBsAg levels during peginterferon α-2a treatment with or without thymosin α-1 in HBeAg-positive chronic hepatitis B patientsEun Young Song, Yunsu Shin, Eun Youn Roh, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|December 28, 2020
Percutaneous Trans-splenic Obliteration for Duodenal Variceal bleeding: A Case ReportHyun Woo Kim, Jun Sik Yoon, Seung Jung Yu, et al.
Journal of Gastroenterology and Hepatology|April 4, 2017
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1Jia-Horng Kao, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Gut and Liver|May 31, 2021
Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III TrialsJeong Heo, Yoon Jun Kim, Jin-Woo Lee, et al.
Scientific Reports|August 31, 2023
Etiology and clinical characteristics of acute viral hepatitis in South Korea during 2020-2021: a prospective multicenter studyChan Young Jeong, Gwang Hyeon Choi, Eun Sun Jang, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2024
High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre studyJun Sik Yoon, Ji Hoon Hong, Soo Young Park, et al.
Hepatology International|July 24, 2015
The virological response in Koreans infected with HCV genotype 1 did not differ between groups treated with a full dose or reduced dose (≥80 % full dose) of peginterferon alfa-2a: a prospective randomized multicenter trialJung Hyun Kwon, Si Hyun Bae, Youn Jae Lee, et al.
Pageof 8